€51.66
0.16% today
Paris, Feb 05, 04:19 pm CET
ISIN
FR0014000MR3
Symbol
ERF

Eurofins Scientific Stock price

€51.58
+1.92 3.87% 1M
-1.60 3.01% 6M
+2.27 4.60% YTD
-1.94 3.62% 1Y
-38.80 42.93% 3Y
+3.30 6.84% 5Y
+28.28 121.37% 10Y
Paris, Closing price Tue, Feb 04 2025
-0.66 1.26%
ISIN
FR0014000MR3
Symbol
ERF
Sector

Key metrics

Market capitalization €9.87b
Enterprise Value €13.91b
P/E (TTM) P/E ratio 24.26
EV/FCF (TTM) EV/FCF 18.07
EV/Sales (TTM) EV/Sales 2.00
P/S ratio (TTM) P/S ratio 1.42
P/B ratio (TTM) P/B ratio 2.33
Dividend yield 0.97%
Last dividend (FY23) €0.50
Revenue growth (TTM) Revenue growth 6.70%
Revenue (TTM) Revenue €6.95b
EBIT (operating result TTM) EBIT €704.00m
Free Cash Flow (TTM) Free Cash Flow €770.00m
EPS (TTM) EPS €2.13
P/E forward 19.40
P/S forward 1.31
EV/Sales forward 1.85
Show more

Is Eurofins Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Eurofins Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Eurofins Scientific forecast:

5x Buy
33%
6x Hold
40%
4x Sell
27%

Analyst Opinions

15 Analysts have issued a Eurofins Scientific forecast:

Buy
33%
Hold
40%
Sell
27%

Financial data from Eurofins Scientific

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
6,951 6,951
7% 7%
100%
- Direct Costs 6,247 6,247
5% 5%
90%
704 704
29% 29%
10%
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
1,301 1,301
7% 7%
19%
- Depreciation and Amortization 597 597
10% 10%
9%
EBIT (Operating Income) EBIT 704 704
29% 29%
10%
Net Profit 404 404
30% 30%
6%

In millions EUR.

Don't miss a Thing! We will send you all news about Eurofins Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World. The company was founded by Gilles G. Martin in 1987 and is headquartered in Luxembourg.

Head office France
CEO Gilles Martin
Founded 2012
Website www.eurofins.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today